Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): A randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Their products are used to treat coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema, inherited respiratory disease and neurological disorders
Insurance is not required to purchase semaglutide from PlexusDx, which expands access for uninsured or underinsured patients
The neurological effects can worsen, potentially leading to permanent cognitive decline, neuropathy, and an increased risk of neurodegenerative diseases like Parkinson's or dementia
What are some symptoms of depression